{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:34:01Z","timestamp":1784892841870,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.hoc.2022.02.008","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T09:35:30Z","timestamp":1652434530000},"page":"569-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management of Peritoneal Disease in Colorectal Cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"Vanessa M.","family":"Welten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelya","family":"Melnitchouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hoc.2022.02.008_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12957-021-02255-w","article-title":"Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy","volume":"19","author":"Zhou","year":"2021","journal-title":"World J Surg Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2022.02.008_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1067\/j.cpsurg.2018.08.004","article-title":"Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?","volume":"55","author":"Stewart","year":"2018","journal-title":"Curr Probl Surg"},{"issue":"5","key":"10.1016\/j.hoc.2022.02.008_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/SLA.0b013e31818a15b5","article-title":"Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?","volume":"248","author":"Yan","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.hoc.2022.02.008_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2147\/CIA.S293412","article-title":"Can elderly patients with peritoneal metastasis induced by appendiceal or colorectal tumours benefit from cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)?","volume":"16","author":"Zhou","year":"2021","journal-title":"Clin Interv Aging"},{"issue":"8","key":"10.1016\/j.hoc.2022.02.008_bib5","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s12094-019-02277-7","article-title":"Different variables predict the outcome of patients with synchronous versus metachronous metastases of colorectal cancer","volume":"22","author":"Colloca","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2022.02.008_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/ans.13969","article-title":"Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer","volume":"88","author":"Suthananthan","year":"2018","journal-title":"ANZ J Surg"},{"issue":"39","key":"10.1016\/j.hoc.2022.02.008_bib7","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.3748\/wjg.v18.i39.5489","article-title":"Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options","volume":"18","author":"Klaver","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.hoc.2022.02.008_bib8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.ejso.2016.03.034","article-title":"Distant metastases in colorectal carcinoma: a proposal for a new M1 subclassification","volume":"42","author":"Merkel","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2022.02.008_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2022.02.008_bib10","unstructured":"Amin MB, American Joint Committee on Cancer., American Cancer Society. AJCC Cancer staging Man. 8th edition\/editor-in-chief, Mahul B. Amin, MD, FCAP ; editors, Stephen B. Edge, MD, FACS and 16 others ; Donna M. Gress, RHIT, CTR - Technical editor ; Laura R. Meyer, CAPM - Managing editor. ed. Chicago IL: American Joint committee on cancer, Springer; 2017. Available at: https:\/\/link.springer.com\/book\/9783319406176."},{"issue":"24","key":"10.1016\/j.hoc.2022.02.008_bib11","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1200\/JCO.2006.07.1142","article-title":"Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma","volume":"24","author":"Yan","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2022.02.008_bib12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.hoc.2022.02.008_bib13","first-page":"164","article-title":"Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture","volume":"32","author":"Sugarbaker","year":"1989","journal-title":"Can J Surg"},{"issue":"3\u20134","key":"10.1016\/j.hoc.2022.02.008_bib14","first-page":"57","article-title":"Management of peritoneal carcinomatosis","volume":"16","author":"Sugarbaker","year":"1989","journal-title":"Acta Med Austriaca"},{"issue":"12","key":"10.1016\/j.hoc.2022.02.008_bib15","article-title":"Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer","volume":"7","author":"Yurttas","year":"2018","journal-title":"J\u00a0Clin Med"},{"issue":"34","key":"10.1016\/j.hoc.2022.02.008_bib16","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.3748\/wjg.v22.i34.7692","article-title":"Pathophysiology of colorectal peritoneal carcinomatosis: role of the peritoneum","volume":"22","author":"Lemoine","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.hoc.2022.02.008_bib17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/codi.15003","article-title":"Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis","volume":"22","author":"Narasimhan","year":"2020","journal-title":"Colorectal Dis"},{"issue":"20","key":"10.1016\/j.hoc.2022.02.008_bib18","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2022.02.008_bib19","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2022.02.008_bib20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/bjc.2014.419","article-title":"Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone","volume":"111","author":"Mirnezami","year":"2014","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.hoc.2022.02.008_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2022.02.008_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2022.02.008_bib23","doi-asserted-by":"crossref","unstructured":"NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN guidelines): colon cancer. January 21 2021.","DOI":"10.1016\/S2152-2650(21)01749-3"},{"key":"10.1016\/j.hoc.2022.02.008_bib24","unstructured":"NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN guidelines): rectal cancer. December 22 2020."},{"issue":"11","key":"10.1016\/j.hoc.2022.02.008_bib25","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.hoc.2022.02.008_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"issue":"27","key":"10.1016\/j.hoc.2022.02.008_bib27","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: optimal management review","volume":"25","author":"S\u00e1nchez-Hidalgo","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.hoc.2022.02.008_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/DCR.0000000000000412","article-title":"Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study","volume":"58","author":"Quere","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.hoc.2022.02.008_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12957-018-1369-7","article-title":"Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy","volume":"16","author":"Canda","year":"2018","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2022.02.008_bib30","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jso.23878","article-title":"Comparison between MRI and CT in prediction of peritoneal carcinomatosis index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist","volume":"111","author":"Torkzad","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2022.02.008_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PPO.0b013e3181a58f30","article-title":"Patient selection for a curative approach to carcinomatosis","volume":"15","author":"Piso","year":"2009","journal-title":"Cancer J"},{"issue":"1","key":"10.1016\/j.hoc.2022.02.008_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. society of surgical oncology","volume":"14","author":"Esquivel","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2022.02.008_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.21068","article-title":"The intraoperative staging systems in the management of peritoneal surface malignancy","volume":"98","author":"Portilla","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hoc.2022.02.008_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"6","key":"10.1016\/j.hoc.2022.02.008_bib35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004230050246","article-title":"Management of peritoneal-surface malignancy: the surgeon's role","volume":"384","author":"Sugarbaker","year":"1999","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"10.1016\/j.hoc.2022.02.008_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jso.21601","article-title":"Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study","volume":"102","author":"Esquivel","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2022.02.008_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2022.02.008_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.suronc.2020.02.010","article-title":"Adding diagnostic laparoscopy to computed tomography for the evaluation of peritoneal metastases in patients with colorectal cancer: A retrospective cohort study","volume":"33","author":"Leimk\u00fchler","year":"2020","journal-title":"Surg Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2022.02.008_bib39","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1245\/s10434-009-0387-7","article-title":"18)F-FDG-PET\/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"16","author":"Pfannenberg","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2022.02.008_bib40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/annonc\/mdt591","article-title":"Metastatic pattern in colorectal cancer is strongly influenced by histological subtype","volume":"25","author":"Hugen","year":"2014","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2022.02.008_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.23784","article-title":"Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology","volume":"111","author":"van Oudheusden","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"issue":"24","key":"10.1016\/j.hoc.2022.02.008_bib42","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","article-title":"Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients","volume":"116","author":"Glehen","year":"2010","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.hoc.2022.02.008_bib43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1634\/theoncologist.2014-0294","article-title":"Hyperthermic Intraperitoneal chemotherapy following cytoreductive surgery improves outcome in patients with primary appendiceal mucinous adenocarcinoma: a pooled analysis from three tertiary care centers","volume":"20","author":"Shaib","year":"2015","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.hoc.2022.02.008_bib44","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1245\/s10434-009-0536-z","article-title":"Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma","volume":"16","author":"Chua","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2022.02.008_bib45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/02656736.2017.1338363","article-title":"Diagnostic and therapeutic laparoscopy in assessment and management of patients with appendiceal neoplasms","volume":"34","author":"Tan","year":"2018","journal-title":"Int J Hyperthermia"},{"issue":"3","key":"10.1016\/j.hoc.2022.02.008_bib46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.suc.2017.01.013","article-title":"Cytoreduction and hyperthermic intraperitoneal chemotherapy in the management of colorectal peritoneal metastasis","volume":"97","author":"Hall","year":"2017","journal-title":"Surg Clin North Am"},{"issue":"10","key":"10.1016\/j.hoc.2022.02.008_bib47","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ejso.2006.06.007","article-title":"Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival","volume":"32","author":"Yan","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2022.02.008_bib48","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1245\/s10434-009-0866-x","article-title":"Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"17","author":"Chua","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"16","key":"10.1016\/j.hoc.2022.02.008_bib49","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2022.02.008_bib50","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.ejso.2019.07.008","article-title":"Referral pathways and outcome of patients with colorectal peritoneal metastasis (CRPM)","volume":"45","author":"Larentzakis","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2022.02.008_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jso.21169","article-title":"Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis","volume":"99","author":"Pelz","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"issue":"13","key":"10.1016\/j.hoc.2022.02.008_bib52","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1245\/s10434-014-3798-z","article-title":"The american society of peritoneal surface malignancies (ASPSM) multiinstitution evaluation of the peritoneal surface disease severity score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosis","volume":"21","author":"Esquivel","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2022.02.008_bib53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.amjsurg.2013.09.021","article-title":"Peritoneal surface disease severity score as a predictor of resectability in the treatment of peritoneal surface malignancies","volume":"207","author":"Yoon","year":"2014","journal-title":"Am J Surg"},{"issue":"13","key":"10.1016\/j.hoc.2022.02.008_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133114","article-title":"Hyperthermic intraperitoneal chemotherapy: a critical review","volume":"13","author":"Ceelen","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.hoc.2022.02.008_bib55","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00384-020-03702-y","article-title":"Oxaliplatin versus mitomycin C in HIPEC for peritoneal metastasis from colorectal cancer: a systematic review and meta-analysis of comparative studies","volume":"35","author":"Zhang","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.hoc.2022.02.008_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.critrevonc.2019.06.014","article-title":"Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer","volume":"142","author":"Wisselink","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2022.02.008_bib57","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jss.2012.01.015","article-title":"A\u00a0comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C","volume":"179","author":"Votanopoulos","year":"2013","journal-title":"J\u00a0Surg Res"},{"issue":"8","key":"10.1016\/j.hoc.2022.02.008_bib58","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/jso.25920","article-title":"Optimal perfusion chemotherapy: a prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer","volume":"121","author":"Woeste","year":"2020","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2022.02.008_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2022.02.008_bib60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12885-019-5545-0","volume":"19","author":"Rovers","year":"2019","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.hoc.2022.02.008_bib61","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamasurg.2021.1642","article-title":"Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: a phase 2 randomized clinical trial","volume":"156","author":"Rovers","year":"2021","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.hoc.2022.02.008_bib62","doi-asserted-by":"crossref","first-page":"e202701","DOI":"10.1001\/jamaoncol.2020.2701","article-title":"Adjuvant systemic chemotherapy vs active surveillance following up-front resection of isolated synchronous colorectal peritoneal metastases","volume":"6","author":"Rovers","year":"2020","journal-title":"JAMA Oncol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:17:50Z","timestamp":1760185070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858822000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0889858822000089"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2022.02.008","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Peritoneal Disease in Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2022.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}